Vaccination News Home Page

http://www.medicinenet.com/script/main/art.asp?li=MNI&articlekey=20958

 

  Advertisement Click here for Payday loans
Medicinenet.com MedicineNet.com  
   


 

Help | Privacy | About Us

Login

Search MedicineNet Add MedicineNet To  Your Favorites

Featured  SmartMed Sites
  Allergies
Asthma
Cancer
Depression
Diabetes
First Aid
High Blood Pressure
HIV
Men's Health
Senior Health
Skin
Women's Health

Complete List Of Condition Sites

650 + More Topics  
Premium Services
Medical Guides (PDF)
  Doctor Select
  Custom Select
Fill a Prescription
Research Assistance
Drugstore Shopping
Become a Subscriber
Services & Tools
Advanced Search
Poison Control Centers
Product Recalls
Community Centers
(message board)
Health Resources
Free Newsletters
My Account

Company Information
Meet the Doctors
Privacy & Security
About Us

 

 
 MedicineNet Home > Allergy Nasal Drug for 2-Year-Olds
Diseases & Conditions   |   Procedures & Tests   |   Medications   |   Dictionary

 

 

Allergy Nasal Drug for 2-Year-Olds

A short article.

For more, please visit the following MedicineNet.com areas:

Frederick Hecht, MD, FAAP, FACMG
Associate Chief Medical Editor, MedicineNet.com


FDA OKs inhaled allergy drug for 2-year-olds

Last Updated: 2002-07-19 13:02:46 -0400

NEW YORK (Reuters Health) - The US Food and Drug Administration (FDA) has approved the allergy drug Nasonex (mometasone furoate), made by Schering-Plough Corp., for use in children as young as 2 years old, the company reported Friday.

In December 1999, the agency cleared the drug for patients aged 3 years and older.

According to Schering-Plough, the approval makes Nasonex the only prescription nasal-inhaled corticosteroid approved for children that young. It was based on a study showing the drug's safety and tolerability in more than 50 children, the company said.

Schering-Plough estimated that allergic rhinitis, or nasal inflammation, affects more than 6 million children each year.

Copyright © 2002 Reuters Limited. All rights reserved. Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.



 

 
MedicineNet Home  |  Condition Sites  |  Help  |  Privacy  |  About Us  |  My Account
Premium Services  |  Advertise with Us  |  Content Licensing 

VeriSign  |  TRUSTe


 

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles.Verify here.

Advertisement

MedicineNet.com

 

 


 

© 1996-2002 MedicineNet, Inc. All rights reserved. Notices and Legal Disclaimer.

Information on this web site is provided for informational purposes only and is not a substitute for professional medical advice. You should not use the information on this web site for diagnosing or treating a medical or health condition. You should carefully read all product packaging. If you have or suspect you have a medical problem, promptly contact your professional healthcare provider.

Statements and information regarding dietary supplements have not been evaluated or approved by the Food and Drug Administration. Please consult your healthcare provider before beginning any course of supplementation or treatment.

 

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.